Reflexology Versus Progressive Muscle Relaxation for Fatigue in Hemodialysis Patients (NCT07575607) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Reflexology Versus Progressive Muscle Relaxation for Fatigue in Hemodialysis Patients
Egypt60 participantsStarted 2026-06-01
Plain-language summary
The goal of this clinical trial is to compare the effects of reflexology and progressive muscle relaxation in reducing fatigue among hemodialysis patients and to determine which intervention provides greater relief from fatigue.
The main question it aims to answer is:
Is there any difference in effectiveness between reflexology and progressive muscle relaxation techniques in reducing fatigue levels among patients undergoing hemodialysis?
Participants will be randomly assigned to one of three groups:
Group 1: 20 participants will receive reflexology therapy 3 times per week for 12 weeks.
Group 2: 20 participants will receive progressive muscle relaxation 3 times per week for 12 weeks.
Group 3: 20 participants will be a control group.
Fatigue and sleep quality will be measured before and after the intervention using:
Fatigue Severity Scale (FSS) Pittsburgh Sleep Quality Index (PSQI) Epworth Sleepiness Scale (ESS)
This study aims to offer a safe, low-cost, non-pharmacological method that can help hemodialysis patients reduce fatigue and improve sleep quality.
Who can participate
Age range
50 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients of both genders aged from 50 to 70 years old.
* Patients are experiencing moderate to severe fatigue (as measured by a standardized fatigue scale).
* Medically stable as determined by the attending nephrologist.
* Able to understand and follow instructions for relaxation techniques
Exclusion Criteria:
* Patients with severe cognitive impairment or psychiatric disorders that interfere with participation.
* Patients with foot ulcers, wounds, or any contraindications for foot reflexology.
* Currently practicing any relaxation or complementary therapies regularly.
* Patients with unstable medical conditions or undergoing treatment changes during the study period.
* History of recent surgery.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change from baseline in Fatigue Severity Scale (FSS) at 12 weeks
Timeframe: Baseline and after 12 weeks of intervention